Despite the ongoing mystery regarding the higher levels of GLP‐1 in individuals with sarcopenia, we have confirmed that consistent GLP‐1 treatment directly affects myoblasts, hindering the process of myogenic differentiation. Here, GLP1R is linked to sarcopenia.